Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04138017 · ClinicalTrials.gov registry record
ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 15
- Enrollment target
NCT04138017 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 15 participants.
The verdict
NCT04138017 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
To evaluate the fusion status of the hindfoot bones after receiving the ViviGen graft, an FDA approved cellular bone matrix. This is used in a population indicated for hindfoot arthrodesis as an alternative to an autograft.
Interventions
- DEVICE ViviGen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-10-23 |
| Est. Completion | 2023-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04138017
The ClinicalTrials.gov registry entry for NCT04138017 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ViviGen is the first listed.
NCT04138017 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04138017 about?
NCT04138017 is a clinical study titled "ViviGen Cellular Bone Matrix for Hindfoot or Ankle Arthrodesis". To evaluate the fusion status of the hindfoot bones after receiving the ViviGen graft, an FDA approved cellular bone matrix. This is used in a population indicated for hindfoot arthrodesis as an alternative to an autograft.
What is the current status of trial NCT04138017?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2018-10-23. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT04138017?
The interventions under investigation include: ViviGen (DEVICE).
Who is sponsoring clinical trial NCT04138017?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.